Suppr超能文献

在接受放化疗早期的非小细胞肺癌患者中,与采用F-18-FDG PET/CT进行定性评估相比,采用PERCIST 1.0时观察者间的一致性得到了改善。

Inter-observer agreement improves with PERCIST 1.0 as opposed to qualitative evaluation in non-small cell lung cancer patients evaluated with F-18-FDG PET/CT early in the course of chemo-radiotherapy.

作者信息

Fledelius Joan, Khalil Azza, Hjorthaug Karin, Frøkiær Jørgen

机构信息

Department of Nuclear Medicine, Herning Regional Hospital, 7400, Herning, Denmark.

Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.

出版信息

EJNMMI Res. 2016 Dec;6(1):71. doi: 10.1186/s13550-016-0223-6. Epub 2016 Sep 22.

Abstract

BACKGROUND

The purpose of this study is to determine whether a qualitative approach or a semi-quantitative approach provides the most robust method for early response evaluation with 2'-deoxy-2'-[(18)F]fluoro-D-glucose (F-18-FDG) positron emission tomography combined with whole body computed tomography (PET/CT) in non-small cell lung cancer (NSCLC). In this study eight Nuclear Medicine consultants analyzed F-18-FDG PET/CT scans from 35 patients with locally advanced NSCLC. Scans were performed at baseline and after 2 cycles of chemotherapy. Each observer used two different methods for evaluation: (1) PET response criteria in solid tumors (PERCIST) 1.0 and (2) a qualitative approach. Both methods allocate patients into one of four response categories (complete and partial metabolic response (CMR and PMR) and stable and progressive metabolic disease (SMD and PMD)). The inter-observer agreement was evaluated using Fleiss' kappa for multiple raters, Cohens kappa for comparison of the two methods, and intraclass correlation coefficients (ICC) for comparison of lean body mass corrected standardized uptake value (SUL) peak measurements.

RESULTS

The agreement between observers when determining the percentage change in SULpeak was "almost perfect", with ICC = 0.959. There was a strong agreement among observers allocating patients to the different response categories with a Fleiss kappa of 0.76 (0.71-0.81). In 22 of the 35 patients, complete agreement was observed with PERCIST 1.0. The agreement was lower when using the qualitative method, moderate, having a Fleiss kappa of 0.60 (0.55-0.64). Complete agreement was achieved in only 10 of the 35 patients. The difference between the two methods was statistically significant (p < 0.005) (chi-squared). Comparing the two methods for each individual observer showed Cohen's kappa values ranging from 0.64 to 0.79, translating into a strong agreement between the two methods.

CONCLUSIONS

PERCIST 1.0 provides a higher overall agreement between observers than the qualitative approach in categorizing early treatment response in NSCLC patients. The inter-observer agreement is in fact strong when using PERCIST 1.0 even when the level of instruction is purposely kept to a minimum in order to mimic the everyday situation. The variability is largely owing to the subjective elements of the method.

摘要

背景

本研究旨在确定定性方法或半定量方法是否能为非小细胞肺癌(NSCLC)患者使用2'-脱氧-2'-[(18)F]氟-D-葡萄糖(F-18-FDG)正电子发射断层扫描联合全身计算机断层扫描(PET/CT)进行早期反应评估提供最可靠的方法。在本研究中,八位核医学顾问分析了35例局部晚期NSCLC患者的F-18-FDG PET/CT扫描结果。扫描在基线时和化疗2个周期后进行。每位观察者使用两种不同的评估方法:(1)实体瘤PET反应标准(PERCIST)1.0和(2)定性方法。两种方法都将患者分为四个反应类别之一(完全和部分代谢反应(CMR和PMR)以及稳定和进展性代谢疾病(SMD和PMD))。使用Fleiss卡方检验评估观察者间的一致性,使用Cohen卡方检验比较两种方法,使用组内相关系数(ICC)比较瘦体重校正标准化摄取值(SUL)峰值测量结果。

结果

观察者在确定SULpeak百分比变化时的一致性“几乎完美”,ICC = 0.959。观察者在将患者分配到不同反应类别方面有很强的一致性,Fleiss卡方值为0.76(0.71 - 0.81)。在35例患者中的22例中,观察到与PERCIST 1.0完全一致。使用定性方法时一致性较低,为中等,Fleiss卡方值为0.60(0.55 - 0.64)。在35例患者中只有10例达成完全一致。两种方法之间的差异具有统计学意义(p < 0.005)(卡方检验)。对每位个体观察者比较两种方法显示Cohen卡方值范围为0.64至0.79,表明两种方法之间有很强的一致性。

结论

在对NSCLC患者早期治疗反应进行分类时,PERCIST 1.0比定性方法在观察者之间提供了更高的总体一致性。即使为了模拟日常情况而故意将指导水平保持在最低限度,使用PERCIST 1.0时观察者间的一致性实际上仍然很强。变异性很大程度上归因于该方法的主观因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0475/5031580/4cb01665cf3d/13550_2016_223_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验